Cardiometabolic medication exposures and cognitive outcomes in Alzheimer's disease
Age Ageing. 2026 Sep 4;55(9):afag263. doi: 10.1093/ageing/afag263.ABSTRACTBACKGROUND: People with dementia are often prescribed cardiometabolic medications; however, the impact of this medication exposome on cognitive trajectories remains unclear.METHODS: We analysed data from National Alzheimer's C

